Company Active LTD

Company profile

Ifast Diagnostics Limited

IFAST Antimicrobial Susceptibility Testing

Ifast Diagnostics Limited is a UK company with status active founded in 2022 based in South East England.

CRN
14027191
Founded
2022
Age
4

Overview

Legal name
IFAST DIAGNOSTICS LIMITED
Region
South East England
Registered address
GROUND FLOOR, 1500 PARKWAY VILLAGE SOLENT BUSINESS PARK
WHITELEY
FAREHAM
UNITED KINGDOM
PO15 7AF
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

13 events
14 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

28 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

14 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MzQ0NDk3M2FkaXF6a2N4

Published 14 Nov 2024 03:21

06 Nov
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ0MjAxNzM5MmFkaXF6a2N4

Published 08 Nov 2024 10:37

05 Nov
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ0MjAxNjkyN2FkaXF6a2N4

Published 05 Nov 2024 10:04

23 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MDY4NTk5NGFkaXF6a2N4

Published 23 Oct 2024 01:49

07 Oct
2024

Memorandum Articles

Incorporation

MA | Transaction MzQzODExNDk3MWFkaXF6a2N4 | Paper/PDF filed

Published 08 Oct 2024 06:30

07 Oct
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURDVUlWMDFhZGlxemtjeA | Paper/PDF filed

Published 08 Oct 2024 06:22

02 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzODEyMDc1OGFkaXF6a2N4

Published 02 Oct 2024 10:07

02 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzODExODc3NmFkaXF6a2N4

Published 02 Oct 2024 09:54

05 Apr
2022

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
1 years

Projects

2023 Collaborative R&D Lead participant

Novel, Rapid, Antimicrobial Susceptibility Test for Bloodstream Infections

1 Aug 2023 to 31 Jul 2024

Awarded
£265,719
Total cost £379,598

Bacteria are increasingly becoming resistant to many of the antibiotics that we use to treat infections that they cause. This is known as Antimicrobial Resistance (AMR) and is one of the WHO's top 10 Global Healthcare Challenges - it directly causes over 1 million deaths per year - more than AIDS and malaria combined - and contributes to many millions mor...

Product types

Collaborative R&D